EuBiologics Holds Investor Relations Meeting for Analyst Community… Routine Corporate Communication

EuBiologics will hold an Investor Relations (IR) meeting for securities analysts on June 9-10, 2026, in Yeouido, Seoul.
The IR aims to enhance understanding of the company and its business progress, conducted in 1:1 meetings.
Key topics include business status update, R&D plans, and Q&A session — routine management communication.
This IR is a routine communication activity with no direct impact on shareholder value or financial metrics, neutral for investment risk and stock outlook.